* Select Medical Holdings Corp SEM.N SEM is expected
to show a
rise in quarterly revenue when it reports results on August 3.
* The Mechanicsburg Pennsylvania-based company is expected
to
report a 4.0% increase in revenue to $1.648 billion from $1.58
billion a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. The company's guidance on
July 19 2023, for the period ended June 30, was for revenue of
$1.670 billion.
* Refinitiv's mean analyst estimate for Select Medical
Holdings
Corp is for earnings of 54 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Select
Medical
Holdings Corp is $37, above its last closing price of $29.92.
The company's guidance on July 19 2023 for the period ended June
30 was for Earnings before Interest and Taxes of USD159
million.The company's guidance on July 19 2023 for the period
ended June 30 was for Earnings before Interest, Taxes,
Depreciation and Amortization of of USD219 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.41 0.44 0.56 Beat 28.1
Dec. 31 2023 0.35 0.36 0.22 Missed -38.8
Sep. 30 2022 0.45 0.45 0.21 Missed -53.7
Jun. 30 2022 0.56 0.55 0.43 Missed -22.2
Mar. 0.26 0.28 0.37 Beat 34.4
31 2022
Dec. 31 2021 0.28 0.31 0.37 Beat 21.1
Sep. 30 2021 0.53 0.52 0.57 Beat 8.9
Jun. 30 2021 0.58 0.56 1.22 Beat 118.3
This summary was machine generated August 2 at 02:08 GMT. All
figures in US dollars unless otherwise stated